Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iñigo Ruiz-Barrio

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Parkinsonism & Related Disorders|April 4, 2025
Tau biomarkers for neurodegenerative diseases: Current state and perspectivesElena Vacchi, Iñigo Ruiz-Barrio, Giorgia Melli
Frontiers in Neurology|May 13, 2022
Genotype-Phenotype Correlation in Progressive Supranuclear Palsy Syndromes: Clinical and Radiological Similarities and SpecificitiesIñigo Ruiz-Barrio, Andrea Horta-Barba, Ignacio Illán-Gala, et al.
Neurology|December 16, 2022
Association Between Orthostatic Hypotension and Dementia in Patients With Parkinson Disease and Multiple System AtrophyIñigo Ruiz Barrio, Yasuo Miki, Zane T Jaunmuktane, et al.
Movement Disorders Clinical Practice|January 2, 2024
Predicting Disability in Progressive Supranuclear Palsy Using Bedside Frontal-Lobe SignsIñigo Ruiz-Barrio, Andrea Horta-Barba, Ignacio Aracil-Bolaños, et al.
Annals of Neurology|August 5, 2024
Prediction of Cognitive Heterogeneity in Parkinson's Disease: A 4-Year Longitudinal Study Using Clinical, Neuroimaging, Biological and Electrophysiological BiomarkersArnau Puig-Davi, Saul Martinez-Horta, Laura Pérez-Carasol, et al.
Brain Communications|June 24, 2026
Practice effects as a dynamic biomarker of early cognitive change in far-from-onset Huntington's diseaseCarla Franch-Marti, Arnau Puig-Davi, Jon Rodriguez-Antiguedad, et al.
Annals of Clinical and Translational Neurology|April 17, 2025
Early Language Impairment as an Integral Part of the Cognitive Phenotype in Huntington's DiseaseArnau Puig-Davi, Carla Franch-Marti, Iñigo Ruiz-Barrio, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 28, 2024
Skin Tau Quantification as a Novel Biomarker in Huntington's DiseaseIñigo Ruiz-Barrio, Anna Vázquez-Oliver, Arnau Puig-Davi, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|March 31, 2026
Spontaneous speech and language measures as predictive biomarkers of clinically meaningful disease progression and neurodegeneration in Huntington's diseaseArnau Puig-Davi, Carla Franch-Marti, Lara Caler-Gameiro, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Parkinsonism & Related Disorders|April 4, 2025
Tau biomarkers for neurodegenerative diseases: Current state and perspectivesElena Vacchi, Iñigo Ruiz-Barrio, Giorgia Melli
Frontiers in Neurology|May 13, 2022
Genotype-Phenotype Correlation in Progressive Supranuclear Palsy Syndromes: Clinical and Radiological Similarities and SpecificitiesIñigo Ruiz-Barrio, Andrea Horta-Barba, Ignacio Illán-Gala, et al.
Neurology|December 16, 2022
Association Between Orthostatic Hypotension and Dementia in Patients With Parkinson Disease and Multiple System AtrophyIñigo Ruiz Barrio, Yasuo Miki, Zane T Jaunmuktane, et al.
Movement Disorders Clinical Practice|January 2, 2024
Predicting Disability in Progressive Supranuclear Palsy Using Bedside Frontal-Lobe SignsIñigo Ruiz-Barrio, Andrea Horta-Barba, Ignacio Aracil-Bolaños, et al.
Annals of Neurology|August 5, 2024
Prediction of Cognitive Heterogeneity in Parkinson's Disease: A 4-Year Longitudinal Study Using Clinical, Neuroimaging, Biological and Electrophysiological BiomarkersArnau Puig-Davi, Saul Martinez-Horta, Laura Pérez-Carasol, et al.
Brain Communications|June 24, 2026
Practice effects as a dynamic biomarker of early cognitive change in far-from-onset Huntington's diseaseCarla Franch-Marti, Arnau Puig-Davi, Jon Rodriguez-Antiguedad, et al.
Annals of Clinical and Translational Neurology|April 17, 2025
Early Language Impairment as an Integral Part of the Cognitive Phenotype in Huntington's DiseaseArnau Puig-Davi, Carla Franch-Marti, Iñigo Ruiz-Barrio, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 28, 2024
Skin Tau Quantification as a Novel Biomarker in Huntington's DiseaseIñigo Ruiz-Barrio, Anna Vázquez-Oliver, Arnau Puig-Davi, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|March 31, 2026
Spontaneous speech and language measures as predictive biomarkers of clinically meaningful disease progression and neurodegeneration in Huntington's diseaseArnau Puig-Davi, Carla Franch-Marti, Lara Caler-Gameiro, et al.
Pageof 1